Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04480086
Brief Title: Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

First Submitted : July 20, 2020
First Submitted that Met QC Criteria : July 20, 2020
First Posted : July 21, 2020

Last Update Submitted that Met QC Criteria : April 26, 2021
Last Update Posted : April 27, 2021